Merryman Communications worked closely with the internal PR team to develop and manage communications and media relations around the publication of major clinical trial results. Medtronic's global OpT2mise study evaluated the comparative effectiveness of insulin pumps vs. daily insulin injections for people with Type 2 diabetes.
- The positive six-month trial results were published in The Lancet, and our goal was to spread the news that insulin pumps proved to be more effective in diabetes management, but also to educate media that 20 million people around the world with type 2 diabetes require insulin to survive.
The online publication occurred immediately before a July 4 holiday weekend.
Resulting coverage earned more than
impressions globally (based on unique visitors/week)
impressions in the U.S.
HealthDay, WebMD, U.S. News and World Report, Yahoo! Health, Medscape, and Endocrine Today are representative of the outlets that covered the news